Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.417, 2003-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US patient time costs for cancer "substantial"
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 523, 2007-01 ,pp. :
Access to resources
Recommend
US patient time costs for cancer "substantial"
Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. :
Costs of inflammatory bowel disease in the US substantial
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. :
Substantial costs likely if US HIV prevention goals fail
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. :
Interstitial cystitis costs "substantial"
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 559, 2008-01 ,pp. :